Biotech Archives - Page 791 of 795

2 minute read

Kiromic BioPharma Announces Completion Of Expanded cGMP Manufacturing Facility To Support Cell Therapy Oncology Pipeline

July 7, 8:20 AM

Construction Completion is One of the Pre-requisites to Beginning the Deltacel™ Clinical Trial Activation Later This Year and Addresses a Key Clinical Hold Citation Kiromic BioPharma, Inc. (NASDAQ:KRBP)

KRBP

1 minute read

Adverum Biotechnologies Cuts Workforce, Prioritizes ADVM-022

By Vandana Singh

July 7, 8:02 AM

Adverum Biotechnologies Inc (NASDAQ:ADVM) announced a restructuring plan, including reductions in headcount and expenses, to prioritize its clinical development of…

ADVM

1 minute read

Senate Finance Committee Probe Reveals How AbbVie Exploits Offshore Subsidiaries To Avoid Tax Bills

By Vandana Singh

July 7, 7:46 AM

Provisions in the 2017 Republican tax law allow AbbVie Inc (NYSE: ABBV) to generate most of its sales in the U.S. while reporting virtually no income in the U.S. for tax purposes.

ABBV

1 minute read

Portage Biotech Bolsters Pipeline With Acquisition Of Four Adenosine Pathway-Targeting Candidates

By Vandana Singh

July 7, 6:58 AM

Portage Biotech Inc (NASDAQ:PRTG) has agreed to acquire Tarus Therapeutics, a private company developing adenosine receptor antagonists. Under the terms of…

PRTG

1 minute read

FDA
News

UPDATE: Clovis Oncology Says FDA Maintains Their Recommendation That Co. Wait For More Mature Overall Survival Data To Submit SNDA

By Michael Horton

July 6, 4:37 PM

-Reuters

CLVS

1 minute read

FDA
News

UPDATE: Clovis Oncology Says Meeting With FDA To Discuss Plans For SNDA Submission For First-Line Maintenance Treatment For Women With Advanced Ovarian Cancer

By Michael Horton

July 6, 4:36 PM

-Reuters

CLVS

1 minute read

Adverum Biotechnologies Completes IND Amendment And Prepares To Initiate The Phase 2 LUNA Trial Of ADVM-022 In Wet AMD

By Benzinga Newsdesk

July 6, 4:10 PM

- Cash runway extended into 2025 due to corporate restructuring to prioritize the clinical development of ADVM-022 and provide additional resources beyond anticipated one-year topline results of the Phase 2 LUNA trial -

ADVM

2 minute read

Calithera Biosciences Announces First Patient Enrolled In Phase 2 Clinical Trial Of Sapanisertib In Relapsed/Refractory NRF2 (NFE2L2)-Mutated Squamous Non-Small Cell Lung Cancer

By Bill Haddad

July 6, 4:01 PM

Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced that it has enrolled the first patient in a phase 2 clinical trial of sapanisertib (CB-228) in

CALA

1 minute read

Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report

By Vandana Singh

July 6, 3:12 PM

Wall Street Journal reported that governments, drugmakers, and vaccination sites are discarding several unused COVID-19 vaccine doses amid declining…

AZN

1 minute read

Touchlight Inks Patent License Agreement With Pfizer

By Vandana Singh

July 6, 3:08 PM

Touchlight, a biotechnology company pioneering enzymatic DNA production, announced a non-exclusive patent license agreement with Pfizer Inc (NYSE:PFE). The pharma giant has…

PFE